Skip to main content

Is corporate funding steering research institutions off track?

As a senior researcher defends his involvement with both Enron and ImClone, we assess the conflicts of interest that can attend corporate funding of research.

Written byDan Ferber
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

URBANA, ILLINOIS — Cancer researcher John Mendelsohn, president of the University of Texas MD Anderson Cancer Center in Houston, has come under fire in the past month for sitting on the corporate boards of both Enron and ImClone while directing the medical center. As corporate funding for university research rises, so do financial conflicts of interest, and ethicists and officials alike are scrambling to keep corporate funding from eroding public trust in research institutions.

In December 2000, the University of Nottingham accepted $5.3 million from British American Tobacco, a multinational tobacco company, to establish Britain's first 'International Centre for Corporate Social Responsibility'. At the time of the award, the company was battling several lawsuits alleging among other things that it knowingly caused fatal diseases to smokers. It was also under investigation for aiding tobacco smugglers.

Throughout Britain, the reaction came like a swift kick in the pants. Within a year, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo